Effect of tiotropium bromide on airway remodeling in a chronic asthma model

Annals of Allergy, Asthma and Immunology

Volumn 109, Issue 1, 2012, Pages 29-35

  Kang, Ji Young ^a   Rhee, Chin Kook ^a   Kim, Ju Sang ^a   Park, Chan Kwon ^a   Kim, Seung Joon ^a   Lee, Sang Haak ^a   Yoon, Hyung Kyu ^a   Kwon, Soon Seog ^a   Kim, Young Kyoon ^a   Lee, Sook Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; TIOTROPIUM BROMIDE;

ACUTE DISEASE; AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CHRONIC DISEASE; COLLAGEN METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EXPERIMENTAL MODEL; FEMALE; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; PLEURA THICKENING; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TH2 CELL;

ACETYLCHOLINE; ACUTE DISEASE; AIRWAY REMODELING; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHOLINERGIC ANTAGONISTS; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MUSCLE, SMOOTH; NEUTROPHILS; OVALBUMIN; PNEUMONIA; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; SCOPOLAMINE DERIVATIVES; TH2 CELLS;

EID: 84862841288     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.05.005     Document Type: Article

References (25)

1. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res. 2006;7:73.
2. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther. 2007;115:208-222. (Pubitemid 47042914)
3. Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care. 2007;52:833-851.
4. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med. 1984;311:421-425. (Pubitemid 14058252)
5. Park HW, Yang MS, Park CS, et al. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy. 2009;64:778-783.
6. Molfino NA, Slutsky AS, Juliá-Serdá G, et al. Assessment of airway tone in asthma: comparison between double lung transplant patients and healthy subjects. Am Rev Respir Dis. 1993;148:1238-1243. (Pubitemid 23326020)
7. Ayala LE, Ahmed T. Is there loss of protective muscarinic receptor mechanism in asthma? Chest. 1989;96:1285-1291. (Pubitemid 20000822)
8. Barnes PJ. Modulation of neurotransmission in airways. Physiol Rev. 1992;72: 699-729.
9. Kanazawa H, Kawaguchi T, Shoji S, et al. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs. Am J Respir Crit Care Med. 1997;155:747-750. (Pubitemid 27085830)
10. Vincken W, van Noord JA, Greefhorst AP, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002;19:209-216. (Pubitemid 34162819)
11. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005;18:75-81. (Pubitemid 40092656)
12. Cho JY, Miller M, Baek KJ, et al. Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling.AmJ Respir Cell Mol Biol. 2004;30:651-661. (Pubitemid 38591216)
13. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551-560. (Pubitemid 38542504)
14. Rhee CK, Lee SY, Kang JY. Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma. Int Arch Allergy Immunol. 2009;148:289-296.
15. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720-1745. (Pubitemid 30329053)
16. Boulet LP, Sterk PJ. Airway remodeling: the future. Eur Respir J. 2007; 30:831-834.
17. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med. 2005;171:1096-1102. (Pubitemid 40663720)
18. Bos IS, Gosens R, Zuidhof AB, et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J. 2007; 30:653-661. (Pubitemid 351194824)
19. Ohta S, Oda N, Yokoe T, et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy. 2010; 40:1266-1275.
20. Wamoto H, Yokoyama A, Shiota N, et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J. 2008;31:1379-1380.
21. Kerstjens HA, Disse B, Schröder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol. 2011;128:308-314.
22. Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci. 2007;80:2270-2273. (Pubitemid 46818281)
23. Matthiesen S, Bahulayan A, Kempkens S, et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol. 2006;35:621-627. (Pubitemid 44901851)
24. Gosens R, Nelemans SA, Grootte Bromhaar MM, et al. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol. 2003;28:257-262. (Pubitemid 36169656)
25. Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011;364:2006-2015.